Literature DB >> 30154183

What is new in paediatric medication safety?

Stacie Kahn1, Erika L Abramson1,2.   

Abstract

Medication-related errors are among the most common medical errors, and studies have shown that the paediatric population is particularly vulnerable. Errors can occur during any step in the medication process. This review article seeks to highlight new advancements in the field of paediatric medication safety at each stage of the medication process, from ordering and transcribing to medication dispensing and administration. We will focus on interventions that are increasingly widely used, such as computerised provider order entry with clinical decision support, barcoding technologies and safe medication administration through technologies pumps (SMART pumps), as well as innovative mobile application devices and workflow management systems that are being piloted at single institutions. By highlighting what is new in paediatric medication safety, as well as the gaps that remain, we hope to continue to foster focus on this critically important area in order to create the safest possible environment for children. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  medical errors; medication safety; technology

Year:  2018        PMID: 30154183     DOI: 10.1136/archdischild-2018-315175

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Interventions to Reduce Pediatric Prescribing Errors in Professional Healthcare Settings: A Systematic Review of the Last Decade.

Authors:  Joachim A Koeck; Nicola J Young; Udo Kontny; Thorsten Orlikowsky; Dirk Bassler; Albrecht Eisert
Journal:  Paediatr Drugs       Date:  2021-05-07       Impact factor: 3.022

2.  Analysis of standard concentrations of continuous infusions in nine Spanish neonatal intensive care units.

Authors:  Amaya De Basagoiti; Xabier Antón; Amaya Calleja; Monike De Miguel; Eneritz Guerra; Begoña Loureiro; Ainara Campino
Journal:  Eur J Hosp Pharm       Date:  2020-06-17

3.  Intravenous drug use in neonatal intensive care units.

Authors:  Amaya De Basagoiti; Alba Fernández; Silvia Mendiola; Monike De Miguel; Eneritz Guerra; Begoña Loureiro; Ainara Campino
Journal:  Eur J Hosp Pharm       Date:  2019-11-21

4.  A mobile device app to reduce prehospital medication errors and time to drug preparation and delivery by emergency medical services during simulated pediatric cardiopulmonary resuscitation: study protocol of a multicenter, prospective, randomized controlled trial.

Authors:  Johan N Siebert; Laurie Bloudeau; Frédéric Ehrler; Christophe Combescure; Kevin Haddad; Florence Hugon; Laurent Suppan; Frédérique Rodieux; Christian Lovis; Alain Gervaix; Sergio Manzano
Journal:  Trials       Date:  2019-11-20       Impact factor: 2.279

5.  Effect of a Mobile App on Prehospital Medication Errors During Simulated Pediatric Resuscitation: A Randomized Clinical Trial.

Authors:  Johan N Siebert; Laurie Bloudeau; Christophe Combescure; Kevin Haddad; Florence Hugon; Laurent Suppan; Frédérique Rodieux; Christian Lovis; Alain Gervaix; Frédéric Ehrler; Sergio Manzano
Journal:  JAMA Netw Open       Date:  2021-08-02

6.  Decision-Making in the Pediatric Emergency Department-A Survey of Guidance Strategies among Residents.

Authors:  Sebastian Gaus; Jeremy Schmidt; Paul Lüse; Winfried Barthlen; Eckard Hamelmann; Hendrik Vossschulte
Journal:  Children (Basel)       Date:  2022-08-09

7.  Patterns of medication errors involving pediatric population reported to the French Medication Error Guichet.

Authors:  Christine Azar; Delphine Allué; Marie B Valnet-Rabier; Laurent Chouchana; Fanny Rocher; Dorothée Durand; Nathalie Grené-Lerouge; Nadine Saleh; Patrick Maison
Journal:  Pharm Pract (Granada)       Date:  2021-06-14

8.  Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review.

Authors:  Adam Sutherland; Denham L Phipps; Stephen Tomlin; Darren M Ashcroft
Journal:  BMC Pediatr       Date:  2019-12-11       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.